Related Content
August 1, 2013 — InspireMD Inc. said the first patient has been enrolled in the Master II IDE clinical trial to evaluate ...
August 01, 2013
May 24, 2013 — InspireMD Inc. announced new six-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion ...
May 24, 2013
November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be ...
November 01, 2012
February 6, 2012 — InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...
February 06, 2012
July 29, 2011 — InspireMD Inc., developer of the MGuard mesh protective stent system, announced that the first patient ...
July 29, 2011
December 17, 2010 – Meta analysis data delivered at the Innovations in Interventional Cardiology 2010 meeting ...
December 17, 2010
September 28, 2010 – A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI ...
September 28, 2010
May 21, 2009 - InspireMD Ltd. said today it completed enrollment for the MAGICAL Trial (MGuard in Acute Myocardial) ...
May 21, 2009August 15, 2007 - InspireMD announced today receipt of orders for its MGuard Coronary stents from key markets in Western ...
August 14, 2007May 23, 2007 — InspireMD has announced this week the enrollment of 19 patients in its First in Man study in a ...
May 21, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now